Park Ha Biological Technology Co. (BYAH) Income Statement: Revenue & Earnings

Park Ha Biological Technology Co. Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Park Ha Biological Technology Co., Ltd. income statement - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2023	FY 2022	FY 2021	FY 2017
Period Ending	Oct 2025	Oct 2024	Oct 2023	Oct 2022	Oct 2021	Dec 2017
Revenue & Gross Profit
Revenue	2.52	2.38	2.46	1.92	0.93	456.00
Cost of Revenue	0.14	0.20	0.31	0.51	0.31	0.00
Gross Profit	2.38	2.19	2.15	1.41	0.62	456.00
Operating Expenses
Research & Development	0.24	0.04	0.03	0.06	0.00	0.00
Selling, General & Administrative	26.11	1.18	0.78	1.15	1.12	338.00
Operating Expenses	26.53	1.39	0.97	1.21	1.12	-752.00
Operating Income	-24.15	0.79	1.18	0.20	-0.50	-296.00
Other Income/Expense
Interest Income	0.01	0.00	0.00	0.00	0.00	-36.00
Interest Expense	0.00	0.00	0.00	0.00	0.00	73.00
Other Income/Expense	0.06	0.00	0.00	-0.01	0.02	23.00
Income
Income Before Tax	-24.08	0.79	1.18	0.19	-0.48	-273.00
Income Tax Expense	0.28	0.31	0.33	0.00	0.00	-79.00
Net Income	-24.36	0.48	0.85	0.19	-0.48	-194.00
Net Income - Continuous Operations	-24.36	0.48	0.85	0.19	-0.48	-194.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	-23.97	0.82	1.20	0.22	-0.46	-282.00
EBIT	-24.08	0.79	1.18	0.20	-0.50	0.00
Depreciation & Amortization	0.11	0.02	0.02	0.03	0.04	14.00
Earnings Per Share
Basic EPS	-41.00	1.00	2.00	-	-1.00	-4.00
Diluted EPS	-41.00	1.00	2.00	-	-1.00	-4.00
Basic Shares Outstanding	0.59	0.50	0.52	0.52	0.50	46.91
Diluted Shares Outstanding	0.59	0.50	0.52	0.52	0.50	46.91